Histogen Valuation
| HSTO Stock | USD 0.03 0 3.57% |
Histogen seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Histogen from evaluating the firm fundamentals such as Shares Outstanding of 4.27 M, return on asset of -0.54, and Return On Equity of -1.2 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Histogen's valuation include:
Price Book 0.0212 | Enterprise Value | Enterprise Value Ebitda 0.199 | Price Sales 4.4966 | Enterprise Value Revenue 2.8893 |
Overvalued
Today
Please note that Histogen's price fluctuation is out of control at this time. Calculation of the real value of Histogen is based on 3 months time horizon. Increasing Histogen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Histogen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Histogen Stock. However, Histogen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.027 | Real 0.0259 | Target 2.0 | Hype 0.03 | Naive 0.0657 |
The intrinsic value of Histogen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Histogen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Histogen helps investors to forecast how Histogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Histogen more accurately as focusing exclusively on Histogen's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Histogen's intrinsic value based on its ongoing forecasts of Histogen's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Histogen's closest peers.
Histogen Cash |
|
Histogen Valuation Trend
Knowing Histogen's actual value is paramount for traders when making sound investment determinations. Using both Histogen's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Histogen Total Value Analysis
Histogen is currently anticipated to have valuation of (4.46 M) with market capitalization of 85.44 K, debt of 4.63 M, and cash on hands of 12.6 M. The negative valuation of Histogen may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Histogen fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(4.46 M) | 85.44 K | 4.63 M | 12.6 M |
Histogen Investor Information
The company has price-to-book (P/B) ratio of 0.02. Some equities with similar Price to Book (P/B) outperform the market in the long run. Histogen recorded a loss per share of 2.81. The entity last dividend was issued on the 27th of May 2020. The firm had 1:20 split on the 3rd of June 2022. Based on the analysis of Histogen's profitability, liquidity, and operating efficiency, Histogen is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.Histogen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Histogen has an asset utilization ratio of 0.0996 percent. This suggests that the Company is making $9.96E-4 for each dollar of assets. An increasing asset utilization means that Histogen is more efficient with each dollar of assets it utilizes for everyday operations.Histogen Ownership Allocation
Roughly 97.15 (percent) of Histogen outstanding shares are held by general public with 2.85 % owned by insiders and only 0.0 pct. by outside corporations.Histogen Profitability Analysis
The company reported the previous year's revenue of 19 K. Net Loss for the year was (12.38 M) with loss before overhead, payroll, taxes, and interest of (3.26 M).About Histogen Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Histogen. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Histogen based exclusively on its fundamental and basic technical indicators. By analyzing Histogen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Histogen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Histogen. We calculate exposure to Histogen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Histogen's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 3.4 M | 3.2 M | |
| Pretax Profit Margin | (2.54) | (2.67) | |
| Operating Profit Margin | (2.54) | (2.67) | |
| Net Loss | (2.54) | (2.66) | |
| Gross Profit Margin | 0.87 | 0.90 |
Histogen Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 3.2 M |
Histogen Current Valuation Indicators
Histogen's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Histogen's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Histogen, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Histogen's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Histogen's worth.When determining whether Histogen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Histogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Histogen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Histogen Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Histogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Histogen. If investors know Histogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Histogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Histogen is measured differently than its book value, which is the value of Histogen that is recorded on the company's balance sheet. Investors also form their own opinion of Histogen's value that differs from its market value or its book value, called intrinsic value, which is Histogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Histogen's market value can be influenced by many factors that don't directly affect Histogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Histogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Histogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Histogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.